Table 2.
CES-Depression | Model A | Model B | Model C | ||||||
---|---|---|---|---|---|---|---|---|---|
Predictor | B | 95% CI | p | B | 95% CI | p | B | 95% CI | p |
Smoking Status | −3.64 | −5.52, −1.75 | .000 | −2.81 | −4.72, −0.90 | .007 | −1.93 | −3.58,−0.28 | .028 |
Smoking Status*Month | 0.09 | −0.17, 0.36 | .484 | 0.09 | −0.17, 0.36 | .393 | 0.18 | −0.08, 0.44 | .180 |
Smoking Status*Cancer Type | −0.00 | −3.81, 3.81 | .867 | 1.71 | −2.20, 5.62 | .486 | −0.80 | −4.19, 2.60 | .653 |
Month | 0.12 | 0.00, 0.24 | .050 | 0.12 | 0.00, 0.24 | .054 | 0.11 | 0.00, 0.22 | .061 |
Cancer Type | −1.06 | −2.95, 0.83 | .274 | −1.33 | −3.28, 0.62 | .184 | −1.75 | −3.50,−0.01 | .050 |
Month*Cancer Type | −0.26 | −0.52, 0.00 | .059 | −0.26 | −0.51, 0.00 | .058 | −0.27 | −0.53,−0.02 | .039 |
| |||||||||
Gender | 2.61 | 0.74, 4.48 | .009 | 1.74 | 0.14, 3.34 | .038 | |||
Age | −0.48 | −0.14, 0.04 | .340 | 0.00 | −0.07, 0.07 | .762 | |||
Stage | 0.65 | −0.18, 1.47 | .132 | 0.39 | −0.31, 1.08 | .285 | |||
Gender*Cancer Type | 4.29 | 0.54, 8.03 | .028 | 2.42 | −0.95, 5.79 | .160 | |||
| |||||||||
Baseline | 0.23 | 0.16, 0.30 | .000 | ||||||
Income | −0.57 | −0.98,−0.17 | .010 | ||||||
Income*Month | −0.11 | −0.17,−0.14 | .003 | ||||||
Income*Cancer Type | 1.05 | 0.20, 1.91 | .019 |
BFI-Fatigue | Model A | Model B | Model C | ||||||
---|---|---|---|---|---|---|---|---|---|
Predictor | B | 95% CI | p | B | 95% CI | p | B | 95% CI | p |
Smoking Status | −5.72 | −10.3,−1.13 | .018 | −5.73 | −10.4,−1.07 | .021 | −3.05 | −7.32, 1.22 | .172 |
Smoking Status*Month | −0.31 | −1.00, 0.39 | .389 | −0.30 | −0.99, 0.39 | .396 | −0.17 | −0.90, 0.55 | .651 |
Smoking Status*Cancer Type | 0.96 | −8.19, 10.1 | .795 | 1.52 | −7.62, 10.7 | .734 | −3.01 | −11.6, 5.56 | .498 |
Month | −0.09 | −0.40, 0.22 | .572 | −0.09 | −0.41, 0.22 | .554 | −0.11 | −0.42, 0.20 | .482 |
Cancer Type | −0.69 | −5.25, 3.88 | .793 | −0.30 | −5.29, 4.69 | .840 | −1.39 | −6.09, 3.30 | .566 |
Month*Cancer Type | −0.23 | −0.92, 0.46 | .521 | −0.23 | −0.92, 0.46 | .512 | −0.27 | −0.97, 0.42 | .444 |
| |||||||||
Gender | 2.35 | −2.27, 6.98 | .321 | 0.77 | −3.47, 5.01 | .726 | |||
Age | 0.05 | −0.16, 0.27 | .622 | 0.13 | −0.05, 0.30 | .152 | |||
Stage | 2.23 | 0.26, 4.20 | .030 | 1.58 | −0.24, 3.39 | .089 | |||
Stage*Cancer Type | −2.25 | −6.22, 1.73 | .279 | −1.46 | −5.11, 2.19 | .442 | |||
| |||||||||
Baseline | 0.37 | 0.22, 0.52 | .000 | ||||||
Income | −1.22 | −2.41,−0.03 | .050 | ||||||
Income*Month | −0.15 | −0.34, 0.05 | .173 | ||||||
Income*Cancer Type | 1.65 | −0.65, 3.95 | .139 |
BPI-Severity | Model A | Model B | Model C | ||||||
---|---|---|---|---|---|---|---|---|---|
Predictor | B | 95% CI | p | B | 95% CI | p | B | 95% CI | p |
Smoking Status | −1.39 | −4.21, 1.43 | .338 | −0.71 | −3.43, 2.02 | .617 | 1.40 | −1.02, 3.82 | .260 |
Smoking Status*Month | 0.08 | −0.26, 0.42 | .643 | 0.08 | −0.26, 0.41 | .648 | 0.20 | −0.13, 0.54 | .242 |
Smoking Status*Cancer Type | 1.41 | −4.21, 7.04 | .627 | 2.72 | −2.46, 7.91 | .311 | 0.48 | −3.67, 4.62 | .799 |
Month | 0.05 | −0.11, 0.22 | .510 | 0.05 | −0.11, 0.22 | .514 | 0.05 | −0.11, 0.21 | .537 |
Cancer Type | −3.57 | −6.37, −0.76 | .016 | −2.84 | −5.75, 0.08 | .064 | −4.30 | −6.83, −1.77 | .002 |
Month*Cancer Type | −0.03 | −0.36, 0.31 | .836 | −0.03 | −0.37, 0.30 | .826 | −0.08 | −0.40, 0.24 | .651 |
| |||||||||
Gender | 2.44 | −0.34, 5.21 | .090 | 1.75 | −0.66, 4.16 | .162 | |||
Age | −0.11 | −0.25, 0.02 | .118 | −0.04 | −0.13, 0.06 | .482 | |||
Stage | 1.34 | 0.21, 2.47 | .025 | 0.48 | −0.46, 1.41 | .320 | |||
| |||||||||
Baseline | 0.37 | 0.25, 0.48 | .000 | ||||||
Income | −0.81 | −1.43, −0.20 | .018 | ||||||
Income*Month | −0.16 | −0.24, −0.07 | .001 | ||||||
Income*Cancer Type | 2.28 | 1.15, 3.41 | .000 |
Notes. Smoking status is coded abstinent at all follow-ups [1] and not abstinent at all follow-ups [0].
CES = Center for Epidemiological Studies, BFI = Brief Fatigue Inventory scale, BPI = Brief Pain Inventory
Model A: The base model assesses abstinent versus not abstinent in the context of Cancer Type (H/N vs. Thoracic) and Month (2, 4, 6, 12).
Model B: This model assesses abstinent versus not abstinent after adding 3 traditional control variables (Age, Gender, & Stage) to the base model (A).
Model C: This model assesses abstinent versus not abstinent after adding 2 variables found to be a predictor of the outcome measure in preliminary analyses – baseline QofL measure and income – to Model B.